...
首页> 外文期刊>Molecular biology reports >A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment
【24h】

A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment

机译:雌激素治疗后,雌激素受体-α阴性雌激素受体-β阳性乳腺癌细胞中新基因STYK1 / NOK上调

获取原文
获取原文并翻译 | 示例
           

摘要

The human STYK1/NOK protein is approximately 30-35% similar to mouse fibroblast growth factor receptor 3 and a kinase homologue in D. melanogaster in the tyrosine protein kinase region. STYK1/NOK was identified as being up regulated in MDA-MB-231, an estrogen receptor-alpha negative breast cancer cell line, following 12 h of estrogen treatment at 1 x 10(-9)M. On further investigation of STYK1/NOK in estrogen treated cell line MDA-MB-231, STYK1/NOK was up regulated at 6 h post treatment when compared to untreated cells. We also investigated the expression levels of STYK1/NOK in other breast cancer cell lines MCF-7, MDA-MB-231, BT-549, and MDA-MB-435S using QRT-PCR. In addition, the analysis of message accumulation was increased with other synthetic estrogen response modifiers. We propose that the regulation of STYK1/NOK is achieved independent of ER alpha and suggests further investigation to the relevance of this kinase in breast cancer progression.
机译:人STYK1 / NOK蛋白与小鼠成纤维细胞生长因子受体3和酪氨酸蛋白激酶区域中的黑腹果蝇中的激酶同源物相似,约为30-35%。在1 x 10(-9)M雌激素治疗12小时后,STYK1 / NOK在MDA-MB-231(一种雌激素受体-α阴性乳腺癌细胞系)中被上调。在进一步研究雌激素处理的细胞系MDA-MB-231中的STYK1 / NOK时,与未处理的细胞相比,STYK1 / NOK在处理后6小时被上调。我们还使用QRT-PCR研究了STYK1 / NOK在其他乳腺癌细胞系MCF-7,MDA-MB-231,BT-549和MDA-MB-435S中的表达水平。此外,使用其他合成的雌激素反应调节剂可以增加对信息积累的分析。我们建议STYK1 / NOK的调节独立于ERα实现,并建议对该激酶在乳腺癌进展中的相关性进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号